396 related articles for article (PubMed ID: 29962862)
21. Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
Bäumler W; Schicho A; Schaible J; Verloh N; Senk K; Wiggermann P; Stroszczynski C; Beyer LP
PLoS One; 2020; 15(11):e0242093. PubMed ID: 33201902
[TBL] [Abstract][Full Text] [Related]
22. Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver.
Chung DJ; Sung K; Osuagwu FC; Wu HH; Lassman C; Lu DS
J Vasc Interv Radiol; 2016 Jan; 27(1):104-11. PubMed ID: 26547121
[TBL] [Abstract][Full Text] [Related]
23. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
[TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones.
Guo Y; Zhang Y; Nijm GM; Sahakian AV; Yang GY; Omary RA; Larson AC
Radiology; 2011 Feb; 258(2):461-8. PubMed ID: 21131581
[TBL] [Abstract][Full Text] [Related]
25. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
[TBL] [Abstract][Full Text] [Related]
26. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
[TBL] [Abstract][Full Text] [Related]
27. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
[TBL] [Abstract][Full Text] [Related]
28. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.
Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP
Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591
[TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation: a new ablation modality--clinical implications.
Rubinsky B; Onik G; Mikus P
Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
[TBL] [Abstract][Full Text] [Related]
30. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
[TBL] [Abstract][Full Text] [Related]
31. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
32. MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model.
Zhang Y; Guo Y; Ragin AB; Lewandowski RJ; Yang GY; Nijm GM; Sahakian AV; Omary RA; Larson AC
Radiology; 2010 Aug; 256(2):424-32. PubMed ID: 20656834
[TBL] [Abstract][Full Text] [Related]
33. Morphologic change in computed tomography of aldosterone-producing adenoma after radiofrequency ablation.
Lee RK; Liu SY; Tong CS; Lee PS; Ng EK; Ahuja AT
Can Assoc Radiol J; 2014 Feb; 65(1):86-90. PubMed ID: 23706869
[TBL] [Abstract][Full Text] [Related]
34. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model.
Schoellnast H; Monette S; Ezell PC; Deodhar A; Maybody M; Erinjeri JP; Stubblefield MD; Single GW; Hamilton WC; Solomon SB
Radiology; 2011 Aug; 260(2):421-7. PubMed ID: 21642418
[TBL] [Abstract][Full Text] [Related]
35. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
[TBL] [Abstract][Full Text] [Related]
36. Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.
Zhang Y; White SB; Nicolai JR; Zhang Z; West DL; Kim DH; Goodwin AL; Miller FH; Omary RA; Larson AC
Radiology; 2014 Jun; 271(3):721-9. PubMed ID: 24555632
[TBL] [Abstract][Full Text] [Related]
37. Comparative Effects of Irreversible Electroporation, Radiofrequency Ablation, and Partial Nephrectomy on Renal Function Preservation in a Porcine Solitary Kidney Model.
Morgan MS; Ozayar A; Lucas E; Friedlander JI; Shakir NA; Cadeddu JA
Urology; 2016 Aug; 94():281-7. PubMed ID: 27155310
[TBL] [Abstract][Full Text] [Related]
38. Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.
Hong CW; Chow L; Turkbey EB; Lencioni R; Libutti SK; Wood BJ
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):409-16. PubMed ID: 26228246
[TBL] [Abstract][Full Text] [Related]
39. Does Drug-Eluting Bead TACE Enhance the Local Effect of IRE? Imaging and Histopathological Evaluation in a Porcine Model.
Isfort P; Rauen P; Na HS; Ito N; von Stillfried S; Kuhl C; Bruners P
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):880-885. PubMed ID: 30737544
[TBL] [Abstract][Full Text] [Related]
40. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
